Cleared Traditional

K962371 - DERMTOME BLADE

K962371 is an FDA 510(k) clearance for DERMTOME BLADE, manufactured by Dsp Worldwide. The device is a Class 1 General & Plastic Surgery device with product code GFD cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K962371 · Dsp Worldwide · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1996
Decision
71d
Days
Class 1
Risk

K962371 is an FDA 510(k) clearance for the DERMTOME BLADE. Classified as Dermatome (product code GFD), Class I - General Controls.

Submitted by Dsp Worldwide (North Attleboro, US). The FDA issued a Cleared decision on August 29, 1996 after a review of 71 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4820 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dsp Worldwide devices

FDA 510(k) Submission Details - K962371

510(k) Number K962371 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 19, 1996
Decision Date August 29, 1996
Days to Decision 71 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 115d · This submission: 71d
Pathway characteristics
Predicate-based equivalence.

GFD Device Classification - Class 1, General Controls

Product Code GFD Dermatome
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4820
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.